Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan

IMPORTANCE: The association between sodium-glucose transport protein 2 inhibitor (SGLT2i) use and the incidence of acute kidney injury (AKI) remains controversial. The benefits of SGLT2i use in patients to reduce AKI requiring dialysis (AKI-D) and concomitant diseases with AKI as well as improve AKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Mu-Chi, Hung, Peir-Haur, Hsiao, Po-Jen, Wu, Laing-You, Chang, Chao-Hsiang, Hsiao, Kai-Yu, Wu, Ming-Ju, Shieh, Jeng-Jer, Huang, Yu-Chuen, Chung, Chi-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947724/
https://www.ncbi.nlm.nih.gov/pubmed/36811856
http://dx.doi.org/10.1001/jamanetworkopen.2023.0453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947724/
https://www.ncbi.nlm.nih.gov/pubmed/36811856
http://dx.doi.org/10.1001/jamanetworkopen.2023.0453

Ejemplares similares